ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

RRP Planning Dosimetry Center, Treatment Planning Projects

March 20, 1987

Love, Avon Foundations Recruit Women For Research.

October 3, 2008

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994